Search

everythinglearnresearchcommunity

for

Search:↓

Women of child-bearing age with androgenic alopecia lose hair density, especially in certain areas, and their hair becomes thinner. They also lose more than twice as much hair as healthy women.

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Myoinositol effectively manages PCOS with fewer side effects than metformin.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

The link between anabolic agents and colorectal cancer risk is unclear.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Minoxidil might partially activate estrogen receptors, affecting hair growth.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Current treatments for androgenetic alopecia are complex and promising, but more research is needed.

Diagnosing PCOS is challenging due to its complex and varied symptoms.